Summary
Bio3 Research Srl (Bio3 Research) is a biopharmaceutical company that undertakes the identification and development of therapeutic agents for diseases related to HMGB1 protein over-expression and HMGB1 biological properties. The company develops proprietary compounds with therapeutic potential in cardiovascular, nephrology and tissue regeneration fields. It pipeline product portfolio includes HMGB1 (High Mobility Group Box 1) for cardiovascular disorders; CTR-1 for cartilage repair; CTR-2 for wound healing; CTR-3 for bone matrix regeneration; and BIOCYSAN for renal disorders. The company collaborates with biopharmaceutical companies, academies and individual scientists. Bio3 Research is headquartered in Milan, Italy.
Bio3 Research Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio3 Research Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 10
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 10
Licensing Agreements 11
Bio3 Research Enters into Licensing Agreement with Xediton Pharma for Biocysan 11
Bio3 Research Plans To Enter Into Licensing Agreement For HMGB1 12
Bio3 Research Srl - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16
List of Tables
Bio3 Research Srl, Pharmaceuticals & Healthcare, Key Facts 1
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio3 Research Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio3 Research Srl, Deals By Therapy Area, 2011 to YTD 2017 8
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 10
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 10
Bio3 Research Enters into Licensing Agreement with Xediton Pharma for Biocysan 11
Bio3 Research Plans To Enter Into Licensing Agreement For HMGB1 12
Bio3 Research Srl, Key Competitors 13
Bio3 Research Srl, Key Employees 14
Bio3 Research Srl, Subsidiaries 15
List of Figures
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8